|
2022-07-01 |
2022-07-01 |
S
Sale
|
Potter Stephen W
Chief Business Officer
Officer
|
8,070
-12.6%
0.77
USD 6,250
|
8,070
-12.6%
|
0.77
|
USD 6,250
|
|
|
2022-05-31 |
2022-05-27 |
S
Sale
|
Reynolds Gerald Anthony
Chief Accounting Officer
Officer
|
3,994
-16.0%
0.85
USD 3,376
|
3,994
-16.0%
|
0.85
|
USD 3,376
|
|
|
2022-02-22 |
2022-02-18 |
S
Sale
|
Washer Susan B.
President and CEO
Executive Director
|
9,950
-6.5%
2.18
USD 21,691
|
9,950
-6.5%
|
2.18
|
USD 21,691
|
|
|
2019-12-30 |
2019-12-26 |
S
Sale
|
Krol Patrick Johan Hendrik
Large shareholder
|
81,162
-4.4%
5.24
USD 425,289
|
81,162
-4.4%
|
5.24
|
USD 425,289
|
|
|
2019-11-26 |
2019-11-19 |
B
Purchase
|
Krol Patrick Johan Hendrik
Large shareholder
|
2,544
+0.1%
2.79
USD 7,098
|
2,544
+0.1%
|
2.79
|
USD 7,098
|
|
|
2018-12-18 |
2018-12-14 |
S
Sale
|
Shearman Mark S
Chief Scientific Officer
Officer
|
3,000
-100.0%
3.35
USD 10,053
|
3,000
-100.0%
|
3.35
|
USD 10,053
|
|
|
2018-12-18 |
2018-12-14 |
B
Purchase
|
Washer Susan B.
President and CEO
Executive Director
|
2,380
+11.7%
3.34
USD 7,949
|
2,380
+11.7%
|
3.34
|
USD 7,949
|
|
|
2018-12-18 |
2018-12-14 |
B
Purchase
|
Rosen James
Non-Executive Director
|
1,000
+inf%
3.38
USD 3,381
|
1,000
+inf%
|
3.38
|
USD 3,381
|
|
|
2018-12-18 |
2018-12-14 |
B
Purchase
|
Sullivan William A.
Chief Financial Officer
Officer
|
3,000
+inf%
3.33
USD 9,990
|
3,000
+inf%
|
3.33
|
USD 9,990
|
|
|
2018-12-18 |
2018-12-14 |
B
Purchase
|
Aliski William
Non-Executive Director
|
500
+6.2%
3.24
USD 1,620
|
500
+6.2%
|
3.24
|
USD 1,620
|
|
|
2018-12-18 |
2018-12-14 |
B
Purchase
|
Aliski William
Non-Executive Director
|
4,300
+116.2%
3.25
USD 13,975
|
4,300
+116.2%
|
3.25
|
USD 13,975
|
|
|
2018-12-18 |
2018-12-14 |
B
Purchase
|
Aliski William
Non-Executive Director
|
1,200
+48.0%
3.24
USD 3,882
|
1,200
+48.0%
|
3.24
|
USD 3,882
|
|
|
2016-11-17 |
2016-11-16 |
B
Purchase
|
Magovcevic Ivana
Non-Executive Director
|
3,000
+inf%
9.63
USD 28,875
|
3,000
+inf%
|
9.63
|
USD 28,875
|
|
|
2016-11-02 |
2016-11-01 |
PS
Planned sale
|
Chulay Jeffrey D.
VP and Chief Medical Officer
Officer
|
1,000
-4.7%
7.05
USD 7,052
|
1,000
-4.7%
|
7.05
|
USD 7,052
|
|
|
2016-09-26 |
2016-09-22 |
B
Purchase
|
Shearman Mark S
Chief Scientific Officer
Officer
|
1,300
+76.5%
8.87
USD 11,531
|
1,300
+76.5%
|
8.87
|
USD 11,531
|
|
|
2016-09-26 |
2016-09-22 |
B
Purchase
|
Shearman Mark S
Chief Scientific Officer
Officer
|
1,700
+inf%
8.87
USD 15,071
|
1,700
+inf%
|
8.87
|
USD 15,071
|
|
|
2016-09-27 |
2016-09-20 |
B
Purchase
|
Potter Stephen W
See Remarks
Officer
|
400
+40.0%
8.69
USD 3,476
|
400
+40.0%
|
8.69
|
USD 3,476
|
|
|
2016-09-20 |
2016-09-19 |
B
Purchase
|
BULLOCK LAWRENCE E
Chief Financial Officer
Officer
|
10,000
+inf%
8.75
USD 87,500
|
10,000
+inf%
|
8.75
|
USD 87,500
|
|
|
2016-09-27 |
2016-09-16 |
B
Purchase
|
Potter Stephen W
See Remarks
Officer
|
1,000
+inf%
8.97
USD 8,970
|
1,000
+inf%
|
8.97
|
USD 8,970
|
|
|
2015-02-24 |
2015-02-23 |
S
Sale
|
GLAXOSMITHKLINE PLC
|
503,150
-25.9%
22.00
USD 11,069,602
|
503,150
-25.9%
|
22.00
|
USD 11,069,602
|
|
|
2015-01-26 |
2015-01-23 |
S
Sale
|
Menichella Daniel L
V.P. & Chief Business Officer
Officer
|
1,996
-100.0%
24.90
USD 49,700
|
1,996
-100.0%
|
24.90
|
USD 49,700
|
|
|
2014-12-23 |
2014-12-22 |
S
Sale
|
Menichella Daniel L
V.P. & Chief Business Officer
Officer
|
9,000
-100.0%
20.83
USD 187,470
|
9,000
-100.0%
|
20.83
|
USD 187,470
|
|
|
2015-02-12 |
2014-12-18 |
S
Sale
|
GLAXOSMITHKLINE PLC
Large shareholder
|
12,000
-0.6%
21.01
USD 252,136
|
12,000
-0.6%
|
21.01
|
USD 252,136
|
|
|
2015-02-12 |
2014-12-17 |
S
Sale
|
GLAXOSMITHKLINE PLC
Large shareholder
|
8,000
-0.4%
21.00
USD 168,000
|
8,000
-0.4%
|
21.00
|
USD 168,000
|
|
|
2015-02-12 |
2014-12-12 |
S
Sale
|
GLAXOSMITHKLINE PLC
Large shareholder
|
7,500
-0.4%
21.24
USD 159,294
|
7,500
-0.4%
|
21.24
|
USD 159,294
|
|
|
2015-02-12 |
2014-12-11 |
S
Sale
|
GLAXOSMITHKLINE PLC
Large shareholder
|
12,500
-0.6%
21.28
USD 266,035
|
12,500
-0.6%
|
21.28
|
USD 266,035
|
|
|
2015-02-12 |
2014-12-10 |
S
Sale
|
GLAXOSMITHKLINE PLC
Large shareholder
|
10,000
-0.5%
21.18
USD 211,760
|
10,000
-0.5%
|
21.18
|
USD 211,760
|
|
|
2014-04-02 |
2014-04-01 |
B
Purchase
|
GLAXOSMITHKLINE PLC
Large shareholder
|
103,762
+5.5%
12.00
USD 1,245,144
|
103,762
+5.5%
|
12.00
|
USD 1,245,144
|
|
|
2014-04-01 |
2014-04-01 |
B
Purchase
|
Rosen James
Non-Executive Director
Large shareholder
|
62,871
+5.5%
12.00
USD 754,452
|
62,871
+5.5%
|
12.00
|
USD 754,452
|
|
|
2014-04-01 |
2014-04-01 |
B
Purchase
|
MedImmune Ventures, Inc.
Large shareholder
|
75,735
+5.5%
12.00
USD 908,820
|
75,735
+5.5%
|
12.00
|
USD 908,820
|
|
|
2014-04-01 |
2014-04-01 |
B
Purchase
|
INTERWEST PARTNERS VIII LP
Large shareholder
|
75,376
+5.5%
12.00
USD 904,512
|
75,376
+5.5%
|
12.00
|
USD 904,512
|
|
|
2014-04-01 |
2014-04-01 |
B
Purchase
|
Alta Partners VIII, L.P.
Large shareholder
|
155,645
+5.5%
12.00
USD 1,867,740
|
155,645
+5.5%
|
12.00
|
USD 1,867,740
|
|
|
2014-04-01 |
2014-04-01 |
B
Purchase
|
Wu Samuel
Non-Executive Director
Large shareholder
|
75,735
+5.5%
12.00
USD 908,820
|
75,735
+5.5%
|
12.00
|
USD 908,820
|
|
|
2014-04-01 |
2014-04-01 |
B
Purchase
|
Carroll Jill
Non-Executive Director
Large shareholder
|
103,762
+5.5%
12.00
USD 1,245,144
|
103,762
+5.5%
|
12.00
|
USD 1,245,144
|
|
|
2014-04-01 |
2014-04-01 |
B
Purchase
|
ORONSKY ARNOLD L
Non-Executive Director
Large shareholder
|
75,736
+5.5%
12.00
USD 908,832
|
75,736
+5.5%
|
12.00
|
USD 908,832
|
|
